Prelude Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,166
| Closed | -$17.5K | – | 1041 |
|
|
2025
Q1 | $17.5K | Sell |
19,166
-15,810
| -45% | -$14.4K | ﹤0.01% | 1044 |
|
|
2024
Q4 | $55.6K | Buy |
34,976
+6,966
| +25% | +$11.1K | ﹤0.01% | 1014 |
|
|
2024
Q3 | $54.9K | Buy |
28,010
+1,600
| +6% | +$3.14K | ﹤0.01% | 1105 |
|
|
2024
Q2 | $43.3K | Buy |
26,410
+6,800
| +35% | +$11.2K | ﹤0.01% | 1059 |
|
|
2024
Q1 | $101K | Buy |
19,610
+3,476
| +22% | +$17.9K | 0.01% | 1085 |
|
|
2023
Q4 | $92.4K | Buy |
+16,134
| New | +$92.4K | 0.01% | 904 |
|
|
2023
Q3 | – | Sell |
-23,900
| Closed | -$102K | – | 1027 |
|
|
2023
Q2 | $102K | Buy |
+23,900
| New | +$102K | 0.01% | 813 |
|